Champions Oncology Inc.
CSBR | NASDAQ
$4.81
$0.00 (0.00%)
At close: Oct 30, 2026, 4:00 PM ET
$4.81
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Market Data
Market Cap $66.95M
Enterprise Value $73.56M
Beta 0.44
Average Volume 10.35K
Shares Outstanding (Diluted) 13.9M
Shares Change YoY 0.79%
Institutional Ownership 42.58%
Exchange NASDAQ
ISIN US15870P3073
Price Performance
Price Change 1M -3.8%
Price Change 3M -10.3%
Price Change 6M -19.7%
Price Change YTD -30.4%
Price Change 1Y -29.7%
Price Change 3Y -11.9%
Price Change 5Y -50.8%
1M CAGR (ann.) -9.3%
1Y CAGR (ann.) -28.9%
5Y CAGR (ann.) -13.9%
All-Time CAGR 11.2%
Valuation
PE Ratio -60.89
Forward PE 48.40
PEG Ratio 0.29
Forward PEG 3.65
PS Ratio 1.10
Forward PS 1.00
PB Ratio 17.20
P/FCF Ratio -10.91
P/Adj. FCF Ratio -8.44
P/OCF Ratio -12.02
EV/Sales 1.21
EV/EBIT -83.03
EV/EBITDA 164.56
EV/FCF -11.99
Earnings Yield -1.6%
FCF Yield -9.2%
Adj. FCF Yield -11.8%
Financial Health
Net Cash $3.49M
Total Debt $10.97M
Cash & Short-Term Investments $4.36M
Total Assets $33.29M
Current Ratio 1.03
Quick Ratio 1.03
Debt / Equity Ratio 2.82
Debt / EBITDA 24.54
Debt / FCF -1.79
OCF / Debt -0.51
Interest Coverage 0.00
Altman Z-Score -0.28
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 49.3%
Operating Profit Margin -1.7%
EBITDA Margin 0.7%
Net Profit Margin -1.9%
FCF Margin -10.1%
Adj. FCF Margin -13.1%
SBC / Revenue 3.0%
SBC Impact (per share) -29.3%
Returns
Return on Assets -3.4%
Return on Equity -27.9%
Return on Invested Capital -6.8%
Return on Capital Employed -7.2%
Return on Tangible Assets -3.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 4.8%
Revenue CAGR 5Y 7.3%
Revenue CAGR 10Y 17.6%
EPS CAGR 3Y 198.8%
EPS CAGR 5Y 41.6%
EPS CAGR 10Y 13.1%
FCF CAGR 3Y -689.0%
FCF CAGR 5Y -1468.7%
FCF CAGR 10Y 14.9%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Dec 15, 2026
EPS Estimate (next Q) $0.02
EPS Growth Est (next Q) 0.0%
Revenue Est (next Q) $16.37M
Revenue Growth Est (next Q) 8.9%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $12.00
Price Target Upside 149.5%
Cash Flow
Operating Cash Flow $-5.56M
Free Cash Flow $-6.14M
Adj. Free Cash Flow $-7.93M
FCF Per Share -$0.44
OCF Per Share -$0.40
OCF/S Ratio -9.2%
Income Statement
Revenue $60.66M
Gross Profit $29.91M
Operating Income $-1.04M
EBITDA $447K
Net Income $-1.14M
EPS (Diluted) -$0.08
Revenue / Employee $283.47K
Profit / Employee $-5.3K
Employees 214
Add to Watchlist
Select watchlists to add or remove CSBR